Evestia Acquires ICRC-Weyer for Global Research Growth
Evestia Clinical has acquired ICRC-Weyer, a long-standing Berlin-based CRO and scientific consultancy, adding specialist capabilities in biostatistics, data management,...
Boehringer & Simcere Partner on New IBD Antibody Treatment
Boehringer Ingelheim has licensed global rights, excluding Greater China, to SIM0709 from Simcere in a deal tied to up...
Nurix Reports Q4 & FY 2025 Financials, Corporate Update
Nurix Therapeutics has initiated Daybreak, a pivotal, single‑arm phase 2 study of its oral BTK degrader bexobrutideg in relapsed/refractory...
PDS Biotech Announces Promising Prostate Cancer Drug Results
PDS Biotechnology reported early clinical data from an NCI-led study showing its investigational tumor-targeted IL-12 immunocytokine, PDS01ADC, combined with...
Mabtech, Sai Life Sciences Forge New Immunology Partnership
Mabtech and Sai Life Sciences have formed a collaboration that designates Sai’s Boston site as a co-marketed U.S. execution...
Surging Sales, EPS Growth in 2025; Profitable Outlook
Sanofi closed 2025 with a sharp acceleration in Q4 performance and set a higher bar for 2026. Fourth-quarter sales...
Roche Reports Strong 2025 Results with 7% Sales Growth
Roche posted a 7% increase in 2025 Group sales at constant exchange rates, with Pharmaceuticals up 9% and Diagnostics...
Roche Reports Surging Sales Growth, Reaching 7% in 2025
Roche posted a stronger-than-expected 2025 finish, with group sales up 7% at constant exchange rates to CHF 61.5 billion,...
Leios & BNC Korea in Breakthrough 10XB-101 Partnership
Leios Therapeutics has licensed regional rights to 10XB-101, its minimally invasive injectable for focal fat reduction and body contouring,...
Enlivex Announces RAIN Token Listing on WhiteBIT Exchange
Enlivex Therapeutics has listed its primary treasury asset, the RAIN token, on WhiteBIT, effective January 21, 2026. WhiteBIT, the...